Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
Oct 9, 2026
Stay Ahead of the Curve: Subscribe Now to Receive Instant Breaking News Alerts Directly to Your Inbox!
- Latest
- Popular
